vimarsana.com

Hellix Investment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Concord Biotech IPO subscribed 14 23 times on day 3 so far, issue closes today

Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.

Abu dhabiAbuz abyUnited arab emiratesHellix investment holdingsMotilal oswal financial servicesAbu dhabi investment authorityGovernment pension fund globalKotak mahindra capital companyMutual fundWf asian reconnaissance fundConcord biotechHellix investmentPolar capital fundsReconnaissance fundAmundi fundsReliance securities

Concord Biotech IPO opens today: Should you subscribe to shield your portfolio?

Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.

Abu dhabiAbuz abyUnited arab emiratesUnited statesRakesh jhunjhunwalaGlenmark lifesciencesSuven pharmaAnand rathiHellix investment holdingsReliance industriesGovernment pension fund globalMutual fundAbu dhabi investment authorityWf asian reconnaissance fundKotak mahindra capital companyConcord biotech

Concord Biotech IPO subscribed 25% in first three hours; employees lead bidding process

Incorporated in 1984, Concord Biotech is a homegrown R&D driven biopharma firm among the global developers and manufacturers of select fermentation-based APIs.

Abu dhabiAbuz abyUnited arab emiratesHellix investment holdingsMutual fundGovernment pension fund globalKotak mahindra capital companyMotilal oswal financial servicesWf asian reconnaissance fundAbu dhabi investment authorityConcord biotechHellix investmentPolar capital fundsReconnaissance fundAmundi fundsMahindra capital company

vimarsana © 2020. All Rights Reserved.